Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language | 12 | 2023 | 205 | 3.040 |
Why?
|
| Neuropsychological Tests | 36 | 2023 | 951 | 2.710 |
Why?
|
| Neuropsychology | 7 | 2026 | 24 | 1.940 |
Why?
|
| Cultural Competency | 6 | 2025 | 51 | 1.720 |
Why?
|
| Dementia | 8 | 2023 | 416 | 1.500 |
Why?
|
| Cognition Disorders | 9 | 2017 | 542 | 1.160 |
Why?
|
| Post-Concussion Syndrome | 3 | 2022 | 50 | 1.070 |
Why?
|
| Longevity | 2 | 2023 | 154 | 0.900 |
Why?
|
| Deep Brain Stimulation | 5 | 2021 | 402 | 0.860 |
Why?
|
| Psychology, Clinical | 1 | 2023 | 4 | 0.810 |
Why?
|
| Acculturation | 1 | 2023 | 61 | 0.770 |
Why?
|
| Health Equity | 1 | 2023 | 76 | 0.710 |
Why?
|
| Clinical Competence | 2 | 2026 | 1019 | 0.630 |
Why?
|
| Parkinson Disease | 6 | 2021 | 701 | 0.620 |
Why?
|
| Brain Concussion | 1 | 2020 | 230 | 0.550 |
Why?
|
| Verbal Learning | 5 | 2017 | 67 | 0.540 |
Why?
|
| Internal Capsule | 1 | 2017 | 50 | 0.520 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2010 | 173 | 0.490 |
Why?
|
| Attention | 4 | 2017 | 192 | 0.450 |
Why?
|
| Guidelines as Topic | 3 | 2026 | 196 | 0.450 |
Why?
|
| Translations | 4 | 2023 | 17 | 0.440 |
Why?
|
| Memory Disorders | 3 | 2012 | 207 | 0.440 |
Why?
|
| Memory | 5 | 2012 | 346 | 0.440 |
Why?
|
| Congresses as Topic | 2 | 2026 | 175 | 0.430 |
Why?
|
| Psychomotor Performance | 3 | 2012 | 173 | 0.430 |
Why?
|
| Aged | 24 | 2023 | 20427 | 0.420 |
Why?
|
| Humans | 51 | 2026 | 127268 | 0.410 |
Why?
|
| Motivation | 2 | 2011 | 323 | 0.370 |
Why?
|
| Malingering | 1 | 2012 | 24 | 0.360 |
Why?
|
| Pallidotomy | 2 | 2008 | 11 | 0.360 |
Why?
|
| Internal-External Control | 1 | 2011 | 74 | 0.350 |
Why?
|
| Mental Recall | 1 | 2011 | 138 | 0.330 |
Why?
|
| Psychophysiologic Disorders | 1 | 2010 | 26 | 0.330 |
Why?
|
| Health Status | 1 | 2011 | 382 | 0.300 |
Why?
|
| Cognition | 2 | 2011 | 785 | 0.290 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2017 | 806 | 0.290 |
Why?
|
| Middle Aged | 26 | 2020 | 27807 | 0.280 |
Why?
|
| United States | 7 | 2023 | 11379 | 0.260 |
Why?
|
| Educational Status | 3 | 2012 | 275 | 0.250 |
Why?
|
| Brain Injuries | 1 | 2012 | 693 | 0.250 |
Why?
|
| Emotions | 3 | 2017 | 357 | 0.240 |
Why?
|
| Education, Graduate | 1 | 2026 | 20 | 0.240 |
Why?
|
| Education, Continuing | 1 | 2026 | 30 | 0.240 |
Why?
|
| Female | 31 | 2022 | 68592 | 0.240 |
Why?
|
| Seizures | 1 | 2010 | 847 | 0.240 |
Why?
|
| Adult | 16 | 2023 | 30530 | 0.230 |
Why?
|
| Models, Educational | 1 | 2025 | 75 | 0.230 |
Why?
|
| Male | 29 | 2022 | 62778 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 835 | 0.220 |
Why?
|
| Depression | 2 | 2021 | 1294 | 0.210 |
Why?
|
| Epilepsy | 1 | 2011 | 844 | 0.210 |
Why?
|
| Young Adult | 8 | 2020 | 9694 | 0.200 |
Why?
|
| Societies | 1 | 2023 | 21 | 0.200 |
Why?
|
| Taiwan | 1 | 2023 | 63 | 0.200 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 2892 | 0.200 |
Why?
|
| Personality | 2 | 2017 | 112 | 0.200 |
Why?
|
| Quality of Life | 2 | 2021 | 2029 | 0.200 |
Why?
|
| Multimorbidity | 1 | 2023 | 25 | 0.200 |
Why?
|
| Brazil | 1 | 2023 | 138 | 0.200 |
Why?
|
| Culturally Competent Care | 1 | 2023 | 50 | 0.190 |
Why?
|
| Macular Edema | 1 | 2022 | 25 | 0.190 |
Why?
|
| Fellowships and Scholarships | 1 | 2026 | 315 | 0.190 |
Why?
|
| China | 1 | 2023 | 277 | 0.190 |
Why?
|
| Cross-Cultural Comparison | 1 | 2022 | 57 | 0.180 |
Why?
|
| Macular Degeneration | 1 | 2022 | 89 | 0.180 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 83 | 0.180 |
Why?
|
| Functional Laterality | 3 | 2012 | 173 | 0.170 |
Why?
|
| Minority Groups | 1 | 2023 | 256 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2022 | 144 | 0.170 |
Why?
|
| Legislation, Medical | 1 | 2020 | 13 | 0.170 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 1 | 2021 | 129 | 0.150 |
Why?
|
| Frontal Lobe | 2 | 2010 | 115 | 0.150 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 6694 | 0.150 |
Why?
|
| Language Tests | 1 | 2018 | 24 | 0.140 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2018 | 13 | 0.140 |
Why?
|
| Restless Legs Syndrome | 1 | 2018 | 17 | 0.140 |
Why?
|
| Curriculum | 1 | 2023 | 766 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 694 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 285 | 0.130 |
Why?
|
| Postoperative Complications | 1 | 2008 | 3073 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2017 | 140 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2026 | 1197 | 0.120 |
Why?
|
| Minnesota | 2 | 2026 | 177 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 74 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 402 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2075 | 0.110 |
Why?
|
| Brain | 2 | 2023 | 3043 | 0.110 |
Why?
|
| Subthalamic Nucleus | 2 | 2012 | 48 | 0.110 |
Why?
|
| Speech Articulation Tests | 2 | 2010 | 7 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2023 | 1867 | 0.100 |
Why?
|
| Frontotemporal Dementia | 2 | 2010 | 67 | 0.090 |
Why?
|
| Mental Processes | 2 | 2011 | 37 | 0.090 |
Why?
|
| Association Learning | 1 | 2012 | 23 | 0.090 |
Why?
|
| Speech Disorders | 1 | 2012 | 47 | 0.090 |
Why?
|
| Medication Adherence | 1 | 2015 | 330 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 951 | 0.090 |
Why?
|
| Psychopathology | 1 | 2011 | 33 | 0.090 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2012 | 84 | 0.090 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2011 | 20 | 0.080 |
Why?
|
| Demography | 1 | 2011 | 238 | 0.080 |
Why?
|
| Somatoform Disorders | 1 | 2011 | 45 | 0.080 |
Why?
|
| Sneddon Syndrome | 1 | 2010 | 3 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 182 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2012 | 821 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 684 | 0.080 |
Why?
|
| Verbal Behavior | 1 | 2010 | 48 | 0.080 |
Why?
|
| Behavior | 1 | 2010 | 69 | 0.080 |
Why?
|
| Dysarthria | 1 | 2010 | 24 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 184 | 0.080 |
Why?
|
| Disease Progression | 3 | 2010 | 2119 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2010 | 115 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 75 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3716 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2011 | 285 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 881 | 0.070 |
Why?
|
| Colombia | 2 | 2019 | 49 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2012 | 17051 | 0.070 |
Why?
|
| Age of Onset | 4 | 2010 | 611 | 0.070 |
Why?
|
| Survival Rate | 2 | 2010 | 2105 | 0.070 |
Why?
|
| Globus Pallidus | 1 | 2008 | 68 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2011 | 221 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 318 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 424 | 0.070 |
Why?
|
| Reaction Time | 1 | 2008 | 156 | 0.070 |
Why?
|
| Self Report | 1 | 2010 | 538 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2010 | 398 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 394 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 654 | 0.060 |
Why?
|
| Child | 2 | 2023 | 25274 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2008 | 461 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 1659 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2015 | 3589 | 0.050 |
Why?
|
| HIV Infections | 1 | 2015 | 1953 | 0.050 |
Why?
|
| Translating | 1 | 2023 | 28 | 0.050 |
Why?
|
| Texas | 1 | 2012 | 3564 | 0.050 |
Why?
|
| Republic of Korea | 1 | 2023 | 51 | 0.050 |
Why?
|
| Vietnam | 1 | 2023 | 64 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 96 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2022 | 39 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2023 | 110 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2995 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 3932 | 0.040 |
Why?
|
| Adolescent | 4 | 2023 | 20141 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 227 | 0.040 |
Why?
|
| Executive Function | 2 | 2011 | 118 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1357 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 221 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 5142 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 233 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 6160 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1596 | 0.030 |
Why?
|
| Veterans | 1 | 2009 | 1742 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 148 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 1432 | 0.030 |
Why?
|
| Prevalence | 2 | 2018 | 2613 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 12570 | 0.030 |
Why?
|
| Psychometrics | 1 | 2019 | 655 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2233 | 0.030 |
Why?
|
| Comorbidity | 2 | 2010 | 1562 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1399 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 6239 | 0.020 |
Why?
|
| Cues | 1 | 2012 | 97 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2012 | 211 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2010 | 4975 | 0.020 |
Why?
|
| Video Recording | 1 | 2012 | 200 | 0.020 |
Why?
|
| Visual Perception | 1 | 2011 | 124 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 241 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 103 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 160 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 410 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 146 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 189 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2010 | 137 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 181 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 766 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 254 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 112 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 504 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 289 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 823 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 538 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 341 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 194 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1484 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 358 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 269 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1216 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 692 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 1788 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2598 | 0.010 |
Why?
|
| Decision Making | 1 | 2009 | 666 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 661 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2009 | 862 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2338 | 0.010 |
Why?
|